325
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Components of metabolic syndrome and prognosis of renal cell cancer

, , &
Pages 435-441 | Received 08 Feb 2017, Accepted 20 Jun 2017, Published online: 26 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qian Zhang, Peng Chen, Renli Tian, Jingteng He, Qipeng Han & Lianhui Fan. (2022) Metabolic Syndrome is an Independent Risk Factor for Fuhrman Grade and TNM Stage of Renal Clear Cell Carcinoma. International Journal of General Medicine 15, pages 143-150.
Read now

Articles from other publishers (4)

Riccardo Campi, Giacomo Rebez, Tobias Klatte, Eduard Roussel, Idir Ouizad, Alexander Ingels, Nicola Pavan, Onder Kara, Selcuk Erdem, Riccardo Bertolo, Umberto Capitanio & Maria Carmen Mir. (2023) Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes. Nature Reviews Urology 20:11, pages 669-681.
Crossref
Ying Liang, Chengguo Zhang, Jun Luo, Yunfeng He, Yao Zhang, Zhen Quan & Lin Yang. (2023) Influence of metabolic syndrome on survival of patients with localized renal clear cell carcinoma: A retrospective cohort study in China. Urologic Oncology: Seminars and Original Investigations 41:5, pages 257.e19-257.e26.
Crossref
Xin Li, Zhen Li, Xiaojing Wu, Muyin Zhang, Lili Xu, Xu Hao, Hao Li, Panpan Qiao & Weiming Wang. (2021) Serum uric acid variability increases the risk of postoperative chronic kidney disease in patients with renal cell carcinoma after radical nephrectomy. Urologic Oncology: Seminars and Original Investigations 39:8, pages 500.e1-500.e7.
Crossref
Jie Liang, Guodong Li, Jun Xu, Tong Wang, Yanyan Jia, Qinghua Zhai, Lihua Qiao, Miao Chen, Yajing Guo & Shujun Zhang. (2018) Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Oncotarget 9:18, pages 14068-14076.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.